Gopalakrishnan Natarajan

831 citations
5 papers · 19 indexed · h-index 3
Topics
Pancreatic and Hepatic Oncology Research (2 papers)Cancer Research and Treatments (2 papers)SARS-CoV-2 and COVID-19 Research (1 paper)
Partner nations
United StatesIndiaFrance

In The Last Decade

Gopalakrishnan Natarajan

5 papers receiving 19 citations

Peers

Gopalakrishnan Natarajan
Comparison fields: 5 of 15
  • Oncology 12
  • Molecular Biology 7
  • Biotechnology 6
  • Immunology 4
  • Surgery 3
Replace Austin Burcham with:
Austin Burcham United States
Aarti Gaba United Kingdom
Lakshmi Chilukuri United States
Hannah Beer United States
Norain Ab. Latif Malaysia
Christin Jungk Germany
Graziella Bosco Spain
Rina Sor United States
Adrienne Greenough United States
K. Sawant India
Gopalakrishnan Natarajan relative to Austin Burcham United States Austin Burcham's profile →
Citations per field
00.5×
Austin Burcham · 1×
Citations per year

Countries citing papers authored by Gopalakrishnan Natarajan

Since Specialization
Citations

This map shows the geographic impact of Gopalakrishnan Natarajan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gopalakrishnan Natarajan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gopalakrishnan Natarajan more than expected).

Fields of papers citing papers by Gopalakrishnan Natarajan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gopalakrishnan Natarajan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gopalakrishnan Natarajan. The network helps show where Gopalakrishnan Natarajan may publish in the future.

Co-authorship network of co-authors of Gopalakrishnan Natarajan

This figure shows the co-authorship network connecting the top 25 collaborators of Gopalakrishnan Natarajan. A scholar is included among the top collaborators of Gopalakrishnan Natarajan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gopalakrishnan Natarajan. Gopalakrishnan Natarajan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 5
2 3
3 1
4 2
5 8

About Gopalakrishnan Natarajan

Gopalakrishnan Natarajan is a scholar working on Biotechnology, Oncology and Immunology, having authored 5 papers that have together received 19 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer Research and Treatments (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Biotechnology (6 citations), Oncology (12 citations) and Immunology (4 citations). Gopalakrishnan Natarajan has collaborated with scholars based in United States, India and France. Frequent co-authors include Thinzar M. Lwin, Surinder K. Batra, Hannah M. Hollandsworth, Michael A. Turner, Robert M. Hoffman, Hiroto Nishino, Sukhwinder Kaur, Kavita Mallya, Ashu Shah and Michael Bouvet. Their work appears in journals such as Journal of Clinical Investigation, Cancer Letters and The American Journal of Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026